Takeda Pharmaceutical Co. Ltd. - Tax Provision

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Tax-Provision" stands at 64.62 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 39.90 Billion JPY for the item "Tax Provision" represents an increase of 51.43 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 39.90 Billion JPY for the item "Tax Provision" represents an increase of 46.35 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 64.62 Billion JPY for the item "Tax Provision" represents an increase of 24.31 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 85.08 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 85.08 Billion Japanese Yens.
The 3 year change is 39.66 Billion Japanese Yens.
The 5 year change is 87.03 Billion Japanese Yens.
The 10 year change is 70.96 Billion Japanese Yens.

The Serie's long term average value is 11.03 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 53.59 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2020, to it's latest available value, on 09/30/2025, is +186.84 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2012, to it's latest available value, on 09/30/2025, is -60.58 Billion.